Detailed text transcripts for TV channel - CNN - 20191230:06:42:00
Targets pik3ca mutations in hr+, her2- mbc, which are common and linked to cancer growth. piqray is taken with fulvestrant after progression on hormone therapy and has been proven to help people with a pik3ca mutation live longer without disease progression. do not take piqray if you've had a severe allergic reaction to it or to any of its ingredients. piqray can cause serious side effects including severe allergic and skin reactions, high blood sugar levels and diarrhea that are common and can be severe, and lung problems known as pneumonitis. tell your doctor right away if you have symptoms ...